A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program

Published:January 14, 2022DOI:https://doi.org/10.1016/j.nurpra.2021.12.013


      • The Donabedian model allowed for the delineation of structure and process to identify cancer genetics quality care outcome successes and deficiencies.
      • The nurse practitioner (NP)-led cancer genetic screening and surveillance program met all quality outcomes.
      • Using NPs for hereditary cancer syndrome screening and cancer surveillance is a highly effective method of delivering preventative cancer services.
      • This model of care can be implemented in all NP practices, anticipating similar outcomes.
      • Adherence scores were higher than expected as attributed to shared decision-making.



      Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes.


      To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program.


      The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients.


      Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitioner–led cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.


      To read this article in full you will need to make a payment


      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fu M.R.
        • Kurant-Thoma E.
        • Starkweather A.
        • Henderson W.A.
        • Cashion A.C.
        • Williams J.K.
        • et al.
        Precision health: a nursing perspective.
        Int J Nurs Sci. 2019; 7: 5-12
      1. Genetic/familial high-risk assessment: colorectal. National Comprehensive Cancer Network.
        • Stoffel E.M.
        • Koeppe E.
        • Everett J.
        • Ulintz P.
        • Kiel M.
        • Osborne J.
        • et al.
        Germline genetic features of young individuals with colorectal cancer.
        Gastroenterology. 2017; 154: 897-905
        • Stoll J.
        • Kupfer S.S.
        Risk assessment and genetic testing for inherited gastrointestinal syndromes.
        J Gastro Hepatol. 2019; 15: 462-470
        • Pierle J.M.
        • Mahon S.M.
        Genetic service delivery models exploring approaches to care for families with hereditary cancer risk.
        Clin J Oncol Nurs. 2019; 23: 60-67
        • Casasanta N.
        • Stark E.
        • McHenry A.
        • et al.
        The perils of single-site genetic testing for hereditary cancer syndromes in the era of next-generation sequencing.
        Oncologist. 2018; 23: 393-396
      2. Healthy People 2020 topics and objectives. Office of Disease Prevention.
        • Syngal S.
        • Brand R.E.
        • Church J.M.
        • et al.
        ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes.
        Am J Gastroenterol. 2015; 110: 223-263
        • Muller C.
        • Matthews L.
        • Kupfer S.S.
        • Weiss J.M.
        Effective identification of Lynch Syndrome in gastroenterology practice.
        Curr Treat Options Gastroenterol. 2019; 17: 666-680https://doi.org/10.1007/s11938-019-00261-1
        • Pollett A.
        Colorectal cancer: Microsatellite instability/mismatch repair testing in the era of digital pathology.
        J Gastroenterol. 2020; 159: 1235-1237https://doi.org/10.1053/j.gastro.2020.08.006
        • Braun D.
        • Yang J.
        • Griffin M.
        • et al.
        A clinical decision support tool to predict cancer risk for commonly tested cancer-related germline mutations.
        J Genet Counsel. 2018; 27: 1187-1199
        • Donabedian A.
        An introduction to quality assurance in health care.
        Oxford University Press, 2003
        • Unim B.
        • Pitini E.
        • Lagerberg T.
        • et al.
        Current genetic service delivery models for the provision of genetic testing in Europe: a systematic review of the literature.
        Front Genet. 2019; 10: 1-27
        • Barr J.A.
        • Tsai L.P.
        • Welch A.
        • et al.
        Current practice for genetic counseling by nurses: an integrative review.
        Int J Nurs Pract. 2017; 24: 1-9


      Carrie A. Thompson, DNP, ANP-BC, OCN, ACGN, is a gastroenterology nurse practitioner and Clinical Lead of Genetics Program Development at Logan Health Kalispell, MT. She can be reached at [email protected] .


      Jane Tiedt, PhD, RN, ANEF, is Associate Professor of Nursing at Gonzaga University, Spokane, WA.


      Mirjeta Beqiri, PhD, MBA, is Program Director of Operations Management at Gonzaga University, Spokane, WA.


      Deborah W. Smith, DNP, FNP-BC, is Senior Lecturer of Nursing at Gonzaga University, Spokane, WA.